CN1141937C - 含有曲马朵的药物组合物用于制备治疗偏头痛或类偏头痛的药物 - Google Patents

含有曲马朵的药物组合物用于制备治疗偏头痛或类偏头痛的药物 Download PDF

Info

Publication number
CN1141937C
CN1141937C CNB998031224A CN99803122A CN1141937C CN 1141937 C CN1141937 C CN 1141937C CN B998031224 A CNB998031224 A CN B998031224A CN 99803122 A CN99803122 A CN 99803122A CN 1141937 C CN1141937 C CN 1141937C
Authority
CN
China
Prior art keywords
migraine
tramadol
headache
treatment
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998031224A
Other languages
English (en)
Chinese (zh)
Other versions
CN1291092A (zh
Inventor
M
M·拉伯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharma GmbH and Co KG
Original Assignee
Viatris GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris GmbH and Co KG filed Critical Viatris GmbH and Co KG
Publication of CN1291092A publication Critical patent/CN1291092A/zh
Application granted granted Critical
Publication of CN1141937C publication Critical patent/CN1141937C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CNB998031224A 1998-02-21 1999-02-17 含有曲马朵的药物组合物用于制备治疗偏头痛或类偏头痛的药物 Expired - Fee Related CN1141937C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19807535A DE19807535A1 (de) 1998-02-21 1998-02-21 Pharmazeutische Kombinationen mit Tramadol
DE19807535.9 1998-02-21

Publications (2)

Publication Number Publication Date
CN1291092A CN1291092A (zh) 2001-04-11
CN1141937C true CN1141937C (zh) 2004-03-17

Family

ID=7858642

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998031224A Expired - Fee Related CN1141937C (zh) 1998-02-21 1999-02-17 含有曲马朵的药物组合物用于制备治疗偏头痛或类偏头痛的药物

Country Status (26)

Country Link
EP (1) EP1056448B1 (de)
JP (1) JP2002503689A (de)
KR (1) KR100567154B1 (de)
CN (1) CN1141937C (de)
AR (1) AR018102A1 (de)
AT (1) ATE257700T1 (de)
AU (1) AU748993B2 (de)
BG (1) BG64888B1 (de)
BR (1) BR9909211A (de)
CZ (1) CZ291941B6 (de)
DE (2) DE19807535A1 (de)
DK (1) DK1056448T3 (de)
EA (1) EA002166B1 (de)
ES (1) ES2212549T3 (de)
HK (1) HK1035143A1 (de)
HU (1) HU225656B1 (de)
IL (1) IL137505A (de)
NO (1) NO327860B1 (de)
NZ (1) NZ506020A (de)
PL (1) PL204075B1 (de)
PT (1) PT1056448E (de)
SK (1) SK284937B6 (de)
TR (1) TR200002411T2 (de)
TW (1) TWI228040B (de)
WO (1) WO1999042095A1 (de)
ZA (1) ZA991212B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1329590A (zh) * 1998-12-02 2002-01-02 达尔文发现有限公司 治疗产品及其应用
DE19940944B4 (de) * 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
WO2001064202A2 (en) * 2000-03-01 2001-09-07 Euro-Celtique S.A. Tramadol for the treatment of functional gastrointestinal disorders
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
DE10108122A1 (de) 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
DE10361596A1 (de) * 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004020220A1 (de) * 2004-04-22 2005-11-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
CA2665841C (en) 2006-10-09 2016-04-05 Charleston Laboratories, Inc. Pharmaceutical compositions
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
EP2756756B1 (de) 2008-04-28 2016-01-06 Zogenix, Inc. Neuartige Formulierungen zur Behandlung von Migräne
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
US20150290211A1 (en) * 2014-04-10 2015-10-15 Locl Pharma, Inc. Pharmaceutical compositions
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
WO2018112061A1 (en) * 2016-12-15 2018-06-21 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis
JP7195660B1 (ja) 2021-09-09 2022-12-26 壽製薬株式会社 口腔内崩壊錠

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
FR2712809B1 (fr) * 1993-11-26 1996-04-12 Union Pharma Scient Appl Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
FR2720936B1 (fr) * 1994-06-08 1997-04-30 Synthelabo Poudres à base de métoclopramide et de paracétamol ou de dérivés d'acide acétylsalicylique.
GB9523566D0 (en) * 1995-11-17 1996-01-17 Euro Celtique Sa Pharmaceutical formulation
FR2741532B1 (fr) * 1995-11-28 1998-08-21 Bouchara Sa Nouvelles compositions pharmaceutiques a action antimigraineuse et leur mode de preparation
GB2313309B (en) * 1996-05-24 2000-01-26 Ninh Thuy On Pharmaceutical compositions comprising a nonsteroidal anti-inflammatory drug and domperidone in the treatment of migraine

Also Published As

Publication number Publication date
HUP0100964A3 (en) 2003-09-29
CN1291092A (zh) 2001-04-11
DE59908305D1 (de) 2004-02-19
NO20004143L (no) 2000-09-27
TR200002411T2 (tr) 2000-12-21
BR9909211A (pt) 2000-11-14
EA002166B1 (ru) 2001-12-24
ZA991212B (en) 1999-08-03
AU3514899A (en) 1999-09-06
BG104758A (en) 2001-04-30
KR100567154B1 (ko) 2006-04-04
PL204075B1 (pl) 2009-12-31
HU225656B1 (en) 2007-05-29
PL342546A1 (en) 2001-06-18
EP1056448B1 (de) 2004-01-14
JP2002503689A (ja) 2002-02-05
NZ506020A (en) 2002-05-31
NO327860B1 (no) 2009-10-05
CZ291941B6 (cs) 2003-06-18
AR018102A1 (es) 2001-10-31
SK284937B6 (sk) 2006-02-02
BG64888B1 (bg) 2006-08-31
IL137505A (en) 2005-07-25
HUP0100964A2 (hu) 2001-08-28
ES2212549T3 (es) 2004-07-16
PT1056448E (pt) 2004-05-31
EA200000862A1 (ru) 2001-02-26
ATE257700T1 (de) 2004-01-15
AU748993B2 (en) 2002-06-13
KR20010041110A (ko) 2001-05-15
DE19807535A1 (de) 1999-08-26
SK12172000A3 (sk) 2001-04-09
HK1035143A1 (en) 2001-11-16
EP1056448A1 (de) 2000-12-06
CZ20002939A3 (cs) 2000-12-13
DK1056448T3 (da) 2004-05-17
NO20004143D0 (no) 2000-08-18
WO1999042095A1 (de) 1999-08-26
TWI228040B (en) 2005-02-21
IL137505A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
CN1141937C (zh) 含有曲马朵的药物组合物用于制备治疗偏头痛或类偏头痛的药物
US6376550B1 (en) Pharmaceutical compositions containing tramadol for migraine
CN104958282B (zh) 他喷他多组合物
US8420624B2 (en) Methods for treating or preventing symptoms of hormonal variations
CN102112127A (zh) 用于实现减肥和治疗肥胖的逐渐增加的剂量方案
JP2007533733A (ja) 食物摂取管理の方法
JP2011057714A (ja) 胃酸分泌阻害組成物
EP1601349A1 (de) Verwendung von dem (1s,2r)-milnacipran-enantiomer zur herstellung eines arzneimittels
EP0591434A1 (de) Verfahren und zusammensetzungen zur behandlung von erbrechen, übelkeit und anderen störungen unter verwendung von optisch reinem s(+)-odansetron
EA003142B1 (ru) Лекарственное средство, обладающее антидепрессивным действием, его применение и способ лечения
EA004101B1 (ru) Применение селективных ингибиторов обратного захвата серотонина быстрого запуска для лечения половой дисфункции
EP1107748A2 (de) Verfahren und zusammenstellungen die optisch reines s(+) vigabatrin verwenden
AU2003224419A1 (en) Orally administrable pharmaceutical formulation
CA2262267C (en) Anti-migraine pharmaceutical compositions and process of using
CN1768760A (zh) 一种含红花总黄酮药物组合物及其制备方法与用途
KR20010099648A (ko) 신규 조성물
US6926906B2 (en) Orally administrable pharmaceutical formulation
WO2003057198A1 (fr) Compositions pharmaceutiques a liberation modifiee
RU2506947C2 (ru) Таблетка пролонгированного высвобождения, содержащая теобромин
CA2684171C (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-4-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
EA003584B1 (ru) Способ стимуляции отказа от курения или его снижения или предупреждения возобновления курения и применение пароксетина или его фармацевтически приемлемых солей или сольватов для получения лекарственного средства
KR20010099647A (ko) 신규 조성물
WO2003070154A2 (en) Orally administrable pharmaceutical formulation comprising pseudoephedrine hydrochloride and process for preparing the same
MXPA00007922A (en) Pharmaceutical combinations containing tramadol
CN1485036A (zh) 复方哌替啶制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: MEDA PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME OR ADDRESS: VIATELESS LIMITED PARTNERSHIP

CP01 Change in the name or title of a patent holder

Address after: German Homburg

Patentee after: MEDA Pharma GmbH & Co. KG

Address before: German Homburg

Patentee before: Viatris GmbH & Co.kg

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040317

Termination date: 20170217

CF01 Termination of patent right due to non-payment of annual fee